Turning TCI Ingredients Into
Commercial Proof
TCI has world-class science — SugarLock's dual enzyme inhibition, GLP-1 Support Formula's 560-participant dataset. What's missing is modern, CGM-native evidence formatted for brand customers.
Tastermonial bridges that gap. We turn your ingredient efficacy into commercially usable proof via CGM-native meal experiments.
The Evidence Gap
TCI Has the Science. The Packaging Is Missing.
What TCI has today
SugarLock: dual α-amylase + α-glucosidase inhibition (comparable to acarbose)
16-subject clinical trial — 2% body fat reduction, 7.4% fasting glucose improvement
GLP-1 Formula: 560-participant weight loss program (-4.9 kg mean)
4 patents (TW, CN, JP), Gold Medal Geneva Inventions
Published in peer-reviewed journals
What's missing
No CGM data — the modern gold standard for glucose-response claims
Small clinical study (n=16) — hard to use commercially
No standardized meal challenge protocol
Evidence lives in journal PDFs, not brand-ready formats
Reducose already published a 37-person CGM crossover (30% iAUC reduction, Nutrients 2024)
Evidence Architecture
A Modular Evidence System
Every TCI product can turn modules on or off without rebuilding the reporting layer. The core template stays fixed; the endpoint panels change by product and claim strategy.
Mechanism Module
In vitro, pathways, benchmark comparators, literature anchor
TCI Application
SugarLock — 68% α-amylase inhibition, dual enzyme mechanism, comparable to acarbose
Acute Meal-Response Module
CGM peak, iAUC, time-to-baseline, insulin, satiety
TCI Application
SugarLock — standardized meal challenge showing glucose curve flattening vs control
Longitudinal Metabolic Module
Weight, waist, fasting markers, body composition, responder profiles
TCI Application
GLP-1 Support Formula — builds on 560-participant weight loss dataset (-4.9 kg)
Gut-Metabolic Module
SCFAs, GI tolerance, microbiome outputs, gut-metabolic segmentation
TCI Application
TCI probiotic / prebiotic / postbiotic portfolio — platform-level evidence
Why Tastermonial
Objective Physiology, Not Surveys
To command premium B2B licensing, TCI requires physiological, tamper-proof biometric data — not abstract 30-day survey regimens.
Subjective Perception
Citruslabs, Radicle Science, People Science
- SurveysPrimary instrument
- Perception StudiesTrial design
- Mostly SubjectiveData type
- Anonymous PanelTarget cohort
Objective Physiology
Tastermonial Platform
- Continuous Glucose MonitoringPrimary instrument
- Meal-Event TriggeredTrial design
- Objective PhysiologicalData type
- Profiled Biohacker CohortTarget cohort
TCI Ingredient Roadmap
Two Ingredients, One Evidence System
SugarLock
Peanut Skin Extract
Start here
Core Acute → CGM meal challenge proof → Brand evidence report
GLP-1 Support Formula
Prebiotic-Postbiotic Blend
Expansion
Metabolic Plus → Satiety VAS + CGM + body comp → Brand dossier
Packages
Choose Your Evidence Package
Start with Core Acute for SugarLock. Expand as TCI's evidence needs grow.
Core Acute
- Mechanism summary
- CGM meal study
- Claim slide
TCI Use Case
Generate CGM-backed proof that SugarLock flattens the glucose curve — the evidence Reducose already has
Metabolic Plus
- Core Acute package
- DEXA body composition
- Fasting labs
TCI Use Case
Extend SugarLock's body fat reduction claims with DEXA-verified visceral fat data
Gut-Metabolic
- Metabolic Plus package
- SCFAs + GI tolerance
- Optional microbiome
TCI Use Case
Evidence layer for TCI's probiotic and postbiotic portfolio — including GLP-1 Support Formula
Deliverables
Four Report Formats for TCI
Every study produces structured deliverables — from TCI's internal sales team to downstream brand customers across 68 countries.
TCI Technical Report
Mechanism + clinical summary in TCI house style for your sales team
Sales / scientific collateral
Brand Customer Dossier
White-label proof pack TCI hands to downstream brand customers
Commercialization for 1,400+ brand partners
Participant Insight Report
Personal CGM and body-composition summary for each study participant
Retention and data quality
Evidence Appendix
Methods, benchmark citations, chart notes, claim guardrails
Buyer diligence and regulatory
SugarLock Evidence Summary
From Mechanism to Commercial Proof
Next Step
Run the SugarLock Pilot
A Core Acute CGM meal challenge for SugarLock. You'll have a brand evidence report that puts SugarLock on par with Reducose — in 1–2 weeks.
Align on SugarLock dose, delivery form, and test meal
TCI ships SugarLock product samples
10–20 participants complete CGM meal challenge
TCI receives brand evidence report + raw endpoint tables
Or reach out directly: hello@tastermonial.com